Market Introduction
The allergies are hypersensitive responses from human immune system to the substance that come in contact with body. Severe allergy can be life threatening which disturb the normal functioning of organs such as asthma causes poor functioning of lungs. The most effective treatment for allergy is to avoid the known allergens, while there are medications such as steroids and antihistamines and other therapies which prevent allergies.
Market Overview and Dynamics
The Asia Pacific allergy treatment market is expected to reach US$ 9,991.64 million by 2028 from US$ 5,662.06 million in 2020; it is estimated to grow with a CAGR of 7.4% from 2021 to 2028. The growth of the market is attributed to increasing adoption of immunotherapy in allergy treatment, and developments in food allergy treatments. However, the lack of awareness about allergy treatments is a key factor restraining the market growth.
Key Market Segments
The Asia Pacific Allergy treatment market, based on the allergy type was segmented into eye allergy, rhinitis, asthma, skin allergy, food allergies, and other allergies. In 2020, the rhinitis segment held the largest share of the market, whereas the food allergies segment is expected to grow at the fastest rate during the coming years.
The Asia Pacific Allergy treatment market, based on the treatment was segmented into anti-allergy drugs, and immunotherapy. In 2020, the anti-allergy drugs segment held the largest share of the market. However, the immunotherapy is expected to grow at the fastest rate during the coming years.
Major Sources and Companies Listed
A few of the primary and secondary sources associated with this report on the Asia Pacific allergy treatment market are Indian College of Allergy, Asthma, and Applied Immunology (ICAAI), Australian Society of Clinical Immunology and Allergy (ASCIA) and National Institute of Allergy and Infectious Diseases (NIAID).
Reasons to buy the report
ASIA PACIFIC ALLERGY TREATMENT MARKET SEGMENTATION
By Allergy Type:
By Treatment:
By Country
• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia Pacific
Company Profiles
• Johnson and Johnson Services, Inc.
• Sanofi
• AbbVie's Inc.
• ALK-Abelló A/S
• Allergy Therapeutics
• Stallergenes Greer
| Report Attribute | Details |
|---|---|
| Market size in 2020 | US$ 5,662.06 Million |
| Market Size by 2028 | US$ 9,991.64 Million |
| CAGR (2021 - 2028) | 7.4% |
| Historical Data | 2018-2019 |
| Forecast period | 2021-2028 |
| Segments Covered |
By Allergy Type
|
| Regions and Countries Covered |
Asia-Pacific
|
| Market leaders and key company profiles |
|
The Asia Pacific Allergy Treatment Market is valued at US$ 5,662.06 Million in 2020, it is projected to reach US$ 9,991.64 Million by 2028.
As per our report Asia Pacific Allergy Treatment Market, the market size is valued at US$ 5,662.06 Million in 2020, projecting it to reach US$ 9,991.64 Million by 2028. This translates to a CAGR of approximately 7.4% during the forecast period.
The Asia Pacific Allergy Treatment Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Allergy Treatment Market report:
The Asia Pacific Allergy Treatment Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Allergy Treatment Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Allergy Treatment Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Asia Pacific Allergy Treatment Market
